TickerFacts.

Nexalin Technology, Inc. (NXL): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.50
Year ended 2025-12-31
2022-12-31: -$0.302023-12-31: -$0.632024-12-31: -$0.832025-12-31: -$0.50-$0.50
2022-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$0.50n/m2026-03-25, From 2025-01-01
2024-12-31-$0.83n/m2026-03-25, From 2024-01-01
2023-12-31-$0.63n/m2025-09-23, From 2023-01-01
2022-12-31-$0.30n/a2024-03-27, From 2022-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Nexalin Technology, Inc. (NXL)2025-12-31-$0.50n/m
Positron Corp (POSC)2025-12-31-$0.34n/m
iTonic Holdings Ltd (ITOC)2025-12-31-$0.32n/m
Guided Therapeutics Inc (GTHP)2025-12-31-$0.04n/m
Hongchang International Co., Ltd (HCIL)2024-12-31$0.00n/a
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$0.00n/a
Neuraxis, Inc (NRXS)2025-12-31-$0.95n/m
Yubo International Biotech Ltd (YBGJ)2025-12-31-$0.01n/m
Nuwellis, Inc. (NUWE)2025-12-31-$25.39n/m

Compare NXL, POSC, ITOC, GTHP side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗